Principal Financial Group
VTYX

Principal Financial Group’s Ventyx Biosciences VTYX Stock Holding History

Principal Financial Group’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,180
Closed -$72.5K – 2470
2024
Q1 		$72.5K Sell
13,180
-61
-0.5% -$279 ﹤0.01% 2308
2023
Q4 		$32.7K Buy
13,241
+418
+3% +$3.97K ﹤0.01% 2360
2023
Q3 		$445K Sell
12,823
-241
-2% -$8.33K ﹤0.01% 1975
2023
Q2 		$428K Buy
13,064
+2,085
+19% +$71.9K ﹤0.01% 1986
2023
Q1 		$368K Sell
10,979
-604
-5% -$23.5K ﹤0.01% 2042
2022
Q4 		$380K Buy
+11,583
New +$343K ﹤0.01% 2043

Other funds holding VTYX

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Principal Financial Group's VTYX Position: Q2 2024 in Review

Principal Financial Group sold out of Ventyx Biosciences (VTYX) in Q2 2024, closing a stake of 13,180 shares — an estimated $72.5K sold.

Principal Financial Group first reported a position in VTYX in Q4 2022 and held it in 6 quarters. The position peaked at $445K in Q3 2023. 117 funds tracked by Wall St. Rank hold VTYX as of Q2 2024.

  • Principal Financial Group reported no remaining Ventyx Biosciences position as of Q2 2024 after selling out during the quarter.
  • Principal Financial Group sold 13,180 Ventyx Biosciences shares in Q2 2024, an estimated $72.5K.
  • Principal Financial Group first reported a position in Ventyx Biosciences in Q4 2022 and held it in 6 quarters.
  • Principal Financial Group's Ventyx Biosciences position peaked at $445K in Q3 2023.
  • 117 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q2 2024.

Based on Principal Financial Group's 13F filing for Q2 2024, filed 29 Jul 2024.